Additional file 1: of Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma

Figure S1. Relationship between biomarker values and number of exacerbations in the previous year in the STRATOS 1 all-comers population (full analysis set). Figure S2. Relationship between biomarker values and region in the STRATOS 1 all-comers population (full analysis set). Figure S3. Relationship between biomarker values and age categories in the STRATOS 1 all-comers population (full analysis set). (DOCX 1067 kb)